Related Experiment Videos
Failure to Treat Torsades de Pointes
Payam Yazdan-Ashoori1, Genevieve Digby1, Adrian Baranchuk1
1Cardiology Division, Kingston General Hospital, Kingston, Ontario, Canada.
Cardiology Research
|March 31, 2017
Summary
This case highlights recurrent Torsades de Pointes (TdP) in a young male with pneumonia despite electrolyte correction and standard treatments for QT prolongation. It underscores the challenges in managing refractory TdP.
Area of Science:
- Cardiology
- Pharmacology
- Intensive Care Medicine
Background:
- Severe community-acquired pneumonia can precipitate serious cardiac complications.
- Certain antibiotics, like moxifloxacin and azithromycin, carry a risk of QT interval prolongation.
Observation:
- A healthy 22-year-old male presented with severe pneumonia, hypokalemia, and hypomagnesemia.
- He developed recurrent Torsades de Pointes (TdP) despite initial treatment with isoproterenol, transvenous pacing, electrolyte correction, and withdrawal of offending medications.
Findings:
- Conventional management strategies for Torsades de Pointes were insufficient in this case.
- Recurrent TdP occurred even after addressing electrolyte imbalances and removing QT-prolonging drugs.
Implications:
- This case emphasizes the need for vigilant cardiac monitoring in patients with pneumonia and electrolyte disturbances.
- It suggests that refractory TdP may require alternative or aggressive therapeutic approaches beyond standard protocols.
- Further research into managing atypical or persistent drug-induced TdP is warranted.